The cancer therapeutics market size is expected to reach US$ 5,31,538.02 million by 2031 from US$ 2,30,423.56 million in 2024. The market is estimated to record a CAGR of 12.8% from 2025 to 2031.

 

Executive Summary and Global Market Analysis

The global cancer therapeutics market is experiencing substantial expansion, primarily driven by the escalating burden of breast and lung cancer and significant investments in oncology research. Cancer therapeutics encompass a diverse range of treatments aimed at managing or curing cancerous conditions. Common treatment approaches include chemotherapy, radiation, immunotherapy, targeted therapy, hormone therapy, surgical interventions, and stem cell therapy. The overarching goal of these strategies is to eradicate or control cancer cells, alleviate associated symptoms, and ultimately improve patient survival rates. Treatment often involves a synergistic combination of multiple therapies, meticulously tailored to the specific cancer type, its stage, and the patient's overall health to maximize therapeutic efficacy.

Download our Sample PDF Report

@ https://www.businessmarketinsights.com/sample/BMIRE00031299

 

Cancer Therapeutics Market Segmentation Analysis

The cancer therapeutics market is systematically analyzed by its key segments: therapy type, indication, and distribution channel.

 

Regarding therapy type, the market is delineated into chemotherapy, targeted therapy, radiation therapy, hormone therapy, and other therapeutic modalities. Chemotherapy commanded the largest market share in 2024.

In terms of indications, the market encompasses blood cancer, lung cancer, breast cancer, colorectal cancer, prostate cancer, stomach cancer, cervical cancer, liver and intrahepatic bile duct cancer, thyroid cancer, and various other indications. Lung cancer secured the largest market share in 2024.

Pertaining to the distribution channel, the market is segmented into hospital pharmacies, retail pharmacies, and online stores. Hospital pharmacies maintained the predominant market share in 2024.

Cancer Therapeutics Market Drivers and Opportunities

According to the World Health Organization, cancer contributes to approximately 1 in every 6 global deaths. In 2022, an estimated 20 million new cancer cases were diagnosed, leading to 9.7 million deaths. Projections indicate a substantial increase in this burden by roughly 77% by 2050, which will place further strain on healthcare systems and communities worldwide. The American Cancer Society highlights that 5–10% of all cancers are hereditary. Numerous genes linked to cancer predisposition have been identified. For example, inherited mutations in genes like BRCA1 and BRCA2 significantly elevate the risk of developing various cancers, including breast, ovarian, and prostate cancer. Breast cancer is recognized as the most prevalent cancer among women globally, with its incidence continuously rising due to factors such as environmental impact, genetic susceptibility, hormonal imbalances, and lifestyle changes. Furthermore, breast cancer remains one of the most common cancers in the U.S.

 

Cancer Therapeutics Market Size and Share Analysis

Considering therapy type, the cancer therapeutics market is subdivided into chemotherapy, targeted therapy, radiation therapy, hormone therapy, and other therapy types. The chemotherapy segment exhibited market dominance in 2024. Chemotherapy's efficacy stems from its cytotoxic drugs, which circulate throughout the body, interrupting or slowing down the growth of cancer cells. Estimates from the National Institutes of Health indicate that approximately 650,000 cancer patients in the US receive chemotherapy annually in oncology clinics.

 

In terms of indications, the market includes blood cancer, lung cancer, breast cancer, colorectal cancer, prostate cancer, stomach cancer, cervical cancer, liver and intrahepatic bile duct cancer, thyroid cancer, and other indications. The lung cancer segment held the largest share of the market in 2024.

 

About Us:

Business Market Insights is a market research platform that provides subscription service for industry and company reports. Our research team has extensive professional expertise in domains such as Electronics & Semiconductor; Aerospace & Defense; Automotive & Transportation; Energy & Power; Healthcare; Manufacturing & Construction; Food & Beverages; Chemicals & Materials; and Technology, Media, & Telecommunications